Biotech | May 06, 2022
ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Deputy Mayor from Addis Ababa (Ethiopia) battled out a rare laryngeal cancer at Yashoda Hospitals Hyderabad
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
With one of the most diverse lung cancer development programs, Novartis is focused on investments to advance the science, drive treatment and make an impact on patients
The launch is yet another first of its kind innovation in India
The peptide-based vaccine induces a t cell-dependent response
Subscribe To Our Newsletter & Stay Updated
